Roth Capital Starts Fate Therapeutics (FATE) at Buy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/27/2026

1. SPY
2. AKAM
3. COST
4. META
5. ZS
6. NVDA
7. AWK
8. DRI
9. ULS
10. PRME

Go back to Roth Capital Starts Fate Therapeutics (FATE) at Buy
FATE THERAPEUTICS (NASDAQ: FATE) Delayed: 2.35 +0.02 (0.86%)
Previous Close $2.33    52 Week High $4.76 
Open $2.34    52 Week Low $1.46 
Day High $2.47    P/E N/A 
Day Low $2.27    EPS $-1.91 
Volume 3,387,242